Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue from China, after the country banned the importation of its DN | Illumina also lowered its annual financial forecast,

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.